Patent · US Active

Quaternary salt CCR2 antagonists

US7799824B2 · kind B2 · utility

9Cited by
3References
35Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 22, 2005
Grant dateSep 21, 2010
Priority date—
Expiry dateOct 14, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2602/42
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Quaternary salt compounds of Formula (I)or pharmaceutically acceptable forms thereof, which are CCR2 antagonists and are useful in preventing, treating or ameliorating CCR2 mediated inflammatory syndromes, disorders or diseases in a subject in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.